nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Levonordefrin—Phenylpropanolamine—obesity	0.174	1	CrCrCtD
Epinephrine—ADRB3—obesity	0.109	0.35	CbGaD
Epinephrine—SLC22A1—obesity	0.065	0.209	CbGaD
Epinephrine—ADRB1—obesity	0.0493	0.158	CbGaD
Epinephrine—TNF—obesity	0.0468	0.15	CbGaD
Epinephrine—ADRB2—obesity	0.0415	0.133	CbGaD
Epinephrine—ADRA1B—Phendimetrazine—obesity	0.0289	0.0835	CbGbCtD
Epinephrine—ADRB2—Phenylpropanolamine—obesity	0.0228	0.0659	CbGbCtD
Epinephrine—ADRA1A—Phendimetrazine—obesity	0.0228	0.0659	CbGbCtD
Epinephrine—ADRB1—Phenylpropanolamine—obesity	0.0224	0.0649	CbGbCtD
Epinephrine—ADRA2C—Methamphetamine—obesity	0.0218	0.0631	CbGbCtD
Epinephrine—ADRA2B—Methamphetamine—obesity	0.0207	0.0598	CbGbCtD
Epinephrine—SLC22A5—Methamphetamine—obesity	0.02	0.0579	CbGbCtD
Epinephrine—ADRA2A—Benzphetamine—obesity	0.018	0.0521	CbGbCtD
Epinephrine—ADRA1A—Benzphetamine—obesity	0.0173	0.0499	CbGbCtD
Epinephrine—ADRA2A—Phenylpropanolamine—obesity	0.0172	0.0497	CbGbCtD
Epinephrine—ADRA1A—Phenylpropanolamine—obesity	0.0165	0.0476	CbGbCtD
Epinephrine—SLC22A5—Cimetidine—obesity	0.0156	0.0452	CbGbCtD
Epinephrine—SLC22A2—Cimetidine—obesity	0.0149	0.0431	CbGbCtD
Epinephrine—ADRA2A—Methamphetamine—obesity	0.0144	0.0416	CbGbCtD
Epinephrine—SLC22A1—Cimetidine—obesity	0.0129	0.0374	CbGbCtD
Epinephrine—CYP1A2—Phentermine—obesity	0.00727	0.021	CbGbCtD
Epinephrine—CYP1A2—Phenylpropanolamine—obesity	0.00693	0.02	CbGbCtD
Epinephrine—CYP2C9—Phentermine—obesity	0.00655	0.0189	CbGbCtD
Epinephrine—CYP1A2—Bupropion—obesity	0.00618	0.0179	CbGbCtD
Epinephrine—CYP2C9—Bupropion—obesity	0.00557	0.0161	CbGbCtD
Epinephrine—CYP3A4—Sibutramine—obesity	0.00502	0.0145	CbGbCtD
Epinephrine—CYP1A2—Cimetidine—obesity	0.00453	0.0131	CbGbCtD
Epinephrine—ADRB3—brown adipose tissue—obesity	0.00436	0.23	CbGeAlD
Epinephrine—CYP2C9—Cimetidine—obesity	0.00409	0.0118	CbGbCtD
Epinephrine—CYP3A4—Benzphetamine—obesity	0.00381	0.011	CbGbCtD
Epinephrine—CYP3A4—Bupropion—obesity	0.00324	0.00936	CbGbCtD
Epinephrine—CYP3A4—Orlistat—obesity	0.00264	0.00763	CbGbCtD
Epinephrine—CYP3A4—Cimetidine—obesity	0.00238	0.00687	CbGbCtD
Epinephrine—PAH—gall bladder—obesity	0.0018	0.0949	CbGeAlD
Epinephrine—Panic reaction—Bupropion—obesity	0.00164	0.0258	CcSEcCtD
Epinephrine—CYP3A4—Topiramate—obesity	0.00155	0.0045	CbGbCtD
Epinephrine—Panic reaction—Topiramate—obesity	0.00104	0.0164	CcSEcCtD
Epinephrine—Blood pressure increased—Phendimetrazine—obesity	0.00104	0.0164	CcSEcCtD
Epinephrine—Mydriasis—Diethylpropion—obesity	0.00093	0.0146	CcSEcCtD
Epinephrine—Blood pressure increased—Phenylpropanolamine—obesity	0.000891	0.014	CcSEcCtD
Epinephrine—ADRBK1—respiratory system—obesity	0.000851	0.0448	CbGeAlD
Epinephrine—Psychotic disorder—Methamphetamine—obesity	0.000841	0.0132	CcSEcCtD
Epinephrine—Nephropathy—Orlistat—obesity	0.000818	0.0129	CcSEcCtD
Epinephrine—Psychotic disorder—Benzphetamine—obesity	0.000811	0.0128	CcSEcCtD
Epinephrine—Blood pressure increased—Diethylpropion—obesity	0.000741	0.0117	CcSEcCtD
Epinephrine—Psychotic disorder—Phendimetrazine—obesity	0.000739	0.0116	CcSEcCtD
Epinephrine—Peripheral coldness—Bupropion—obesity	0.00069	0.0109	CcSEcCtD
Epinephrine—ADRBK1—cardiovascular system—obesity	0.000652	0.0343	CbGeAlD
Epinephrine—Psychotic disorder—Phenylpropanolamine—obesity	0.000631	0.00994	CcSEcCtD
Epinephrine—Cerebrovascular accident—Phentermine—obesity	0.000631	0.00994	CcSEcCtD
Epinephrine—Sweating—Benzphetamine—obesity	0.000613	0.00966	CcSEcCtD
Epinephrine—Psychotic disorder—Phentermine—obesity	0.000604	0.00951	CcSEcCtD
Epinephrine—ADRB3—adipose tissue—obesity	0.000588	0.031	CbGeAlD
Epinephrine—PAH—endocrine gland—obesity	0.000586	0.0308	CbGeAlD
Epinephrine—Supraventricular tachycardia—Sibutramine—obesity	0.000575	0.00906	CcSEcCtD
Epinephrine—ADRBK1—adipose tissue—obesity	0.000575	0.0303	CbGeAlD
Epinephrine—Disorientation—Cimetidine—obesity	0.000572	0.00901	CcSEcCtD
Epinephrine—Sweating—Phendimetrazine—obesity	0.000559	0.0088	CcSEcCtD
Epinephrine—Cerebrovascular accident—Diethylpropion—obesity	0.000549	0.00865	CcSEcCtD
Epinephrine—ADRBK1—digestive system—obesity	0.000541	0.0285	CbGeAlD
Epinephrine—Renal impairment—Cimetidine—obesity	0.000538	0.00847	CcSEcCtD
Epinephrine—PAH—liver—obesity	0.000528	0.0278	CbGeAlD
Epinephrine—Psychotic disorder—Diethylpropion—obesity	0.000526	0.00827	CcSEcCtD
Epinephrine—ADRBK1—adrenal gland—obesity	0.000516	0.0272	CbGeAlD
Epinephrine—Supraventricular tachycardia—Bupropion—obesity	0.000501	0.00789	CcSEcCtD
Epinephrine—Psychotic disorder—Cimetidine—obesity	0.0005	0.00787	CcSEcCtD
Epinephrine—Drowsiness—Phenylpropanolamine—obesity	0.000498	0.00784	CcSEcCtD
Epinephrine—Ventricular fibrillation—Sibutramine—obesity	0.000492	0.00775	CcSEcCtD
Epinephrine—Flushing—Phendimetrazine—obesity	0.000486	0.00765	CcSEcCtD
Epinephrine—Agitation—Methamphetamine—obesity	0.000477	0.0075	CcSEcCtD
Epinephrine—Acute coronary syndrome—Phentermine—obesity	0.00047	0.0074	CcSEcCtD
Epinephrine—Myocardial infarction—Phentermine—obesity	0.000467	0.00736	CcSEcCtD
Epinephrine—ADRA1A—hindbrain—obesity	0.000461	0.0243	CbGeAlD
Epinephrine—Agitation—Benzphetamine—obesity	0.00046	0.00723	CcSEcCtD
Epinephrine—Palpitations—Methamphetamine—obesity	0.000458	0.00721	CcSEcCtD
Epinephrine—Sweating increased—Diethylpropion—obesity	0.000453	0.00713	CcSEcCtD
Epinephrine—ADRBK1—endocrine gland—obesity	0.000447	0.0236	CbGeAlD
Epinephrine—Hallucination—Phenylpropanolamine—obesity	0.000445	0.00701	CcSEcCtD
Epinephrine—Palpitations—Benzphetamine—obesity	0.000442	0.00696	CcSEcCtD
Epinephrine—Peripheral coldness—Topiramate—obesity	0.00044	0.00692	CcSEcCtD
Epinephrine—Nephropathy—Topiramate—obesity	0.00044	0.00692	CcSEcCtD
Epinephrine—Contusion—Sibutramine—obesity	0.000432	0.0068	CcSEcCtD
Epinephrine—Hallucination—Phentermine—obesity	0.000426	0.0067	CcSEcCtD
Epinephrine—Drug interaction—Orlistat—obesity	0.00042	0.00661	CcSEcCtD
Epinephrine—Agitation—Phendimetrazine—obesity	0.000419	0.00659	CcSEcCtD
Epinephrine—Memory impairment—Bupropion—obesity	0.000419	0.00659	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Sibutramine—obesity	0.000417	0.00657	CcSEcCtD
Epinephrine—Flushing—Phenylpropanolamine—obesity	0.000415	0.00653	CcSEcCtD
Epinephrine—Drowsiness—Diethylpropion—obesity	0.000415	0.00653	CcSEcCtD
Epinephrine—Tachycardia—Methamphetamine—obesity	0.000413	0.0065	CcSEcCtD
Epinephrine—Mydriasis—Bupropion—obesity	0.000412	0.00649	CcSEcCtD
Epinephrine—Palpitations—Phendimetrazine—obesity	0.000403	0.00634	CcSEcCtD
Epinephrine—Arrhythmia—Phenylpropanolamine—obesity	0.0004	0.00629	CcSEcCtD
Epinephrine—Tachycardia—Benzphetamine—obesity	0.000398	0.00627	CcSEcCtD
Epinephrine—Pallor—Bupropion—obesity	0.000396	0.00624	CcSEcCtD
Epinephrine—Drowsiness—Cimetidine—obesity	0.000395	0.00621	CcSEcCtD
Epinephrine—Hyperhidrosis—Benzphetamine—obesity	0.000395	0.00621	CcSEcCtD
Epinephrine—Renal failure—Cimetidine—obesity	0.000388	0.00611	CcSEcCtD
Epinephrine—Insomnia—Methamphetamine—obesity	0.000383	0.00603	CcSEcCtD
Epinephrine—Tension—Phenylpropanolamine—obesity	0.000382	0.00601	CcSEcCtD
Epinephrine—Nervousness—Phenylpropanolamine—obesity	0.000378	0.00595	CcSEcCtD
Epinephrine—Blood pressure increased—Sibutramine—obesity	0.000377	0.00593	CcSEcCtD
Epinephrine—Contusion—Bupropion—obesity	0.000377	0.00593	CcSEcCtD
Epinephrine—Insomnia—Benzphetamine—obesity	0.000369	0.00581	CcSEcCtD
Epinephrine—Tension—Phentermine—obesity	0.000366	0.00576	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Methamphetamine—obesity	0.000365	0.00575	CcSEcCtD
Epinephrine—Tachycardia—Phendimetrazine—obesity	0.000363	0.00572	CcSEcCtD
Epinephrine—Nervousness—Phentermine—obesity	0.000362	0.0057	CcSEcCtD
Epinephrine—Hyperhidrosis—Phendimetrazine—obesity	0.00036	0.00566	CcSEcCtD
Epinephrine—Agitation—Phenylpropanolamine—obesity	0.000358	0.00563	CcSEcCtD
Epinephrine—Hallucination—Cimetidine—obesity	0.000352	0.00555	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Benzphetamine—obesity	0.000352	0.00555	CcSEcCtD
Epinephrine—Agitation—Phentermine—obesity	0.000342	0.00539	CcSEcCtD
Epinephrine—Insomnia—Phendimetrazine—obesity	0.000336	0.0053	CcSEcCtD
Epinephrine—SLC22A2—digestive system—obesity	0.000333	0.0175	CbGeAlD
Epinephrine—Arrhythmia—Diethylpropion—obesity	0.000333	0.00524	CcSEcCtD
Epinephrine—Palpitations—Phentermine—obesity	0.000329	0.00518	CcSEcCtD
Epinephrine—Blood pressure increased—Bupropion—obesity	0.000329	0.00517	CcSEcCtD
Epinephrine—Erythema—Diethylpropion—obesity	0.000324	0.0051	CcSEcCtD
Epinephrine—Hypertension—Phentermine—obesity	0.000322	0.00506	CcSEcCtD
Epinephrine—Tension—Diethylpropion—obesity	0.000318	0.00501	CcSEcCtD
Epinephrine—Chest pain—Phentermine—obesity	0.000317	0.00499	CcSEcCtD
Epinephrine—Nervousness—Diethylpropion—obesity	0.000315	0.00496	CcSEcCtD
Epinephrine—Tachycardia—Phenylpropanolamine—obesity	0.00031	0.00488	CcSEcCtD
Epinephrine—Agitation—Diethylpropion—obesity	0.000298	0.00469	CcSEcCtD
Epinephrine—Tachycardia—Phentermine—obesity	0.000297	0.00467	CcSEcCtD
Epinephrine—Hypoglycaemia—Orlistat—obesity	0.00029	0.00456	CcSEcCtD
Epinephrine—Isoprenaline—PIK3R1—obesity	0.000289	0.0915	CrCbGaD
Epinephrine—Renal impairment—Sibutramine—obesity	0.000287	0.00453	CcSEcCtD
Epinephrine—Insomnia—Phenylpropanolamine—obesity	0.000287	0.00452	CcSEcCtD
Epinephrine—Palpitations—Diethylpropion—obesity	0.000286	0.00451	CcSEcCtD
Epinephrine—Agitation—Cimetidine—obesity	0.000283	0.00446	CcSEcCtD
Epinephrine—Somnolence—Phenylpropanolamine—obesity	0.000282	0.00445	CcSEcCtD
Epinephrine—Hypoglycaemia—Sibutramine—obesity	0.00028	0.00441	CcSEcCtD
Epinephrine—Dizziness—Methamphetamine—obesity	0.00028	0.00441	CcSEcCtD
Epinephrine—Cerebrovascular accident—Sibutramine—obesity	0.000279	0.0044	CcSEcCtD
Epinephrine—Chest pain—Diethylpropion—obesity	0.000276	0.00434	CcSEcCtD
Epinephrine—Insomnia—Phentermine—obesity	0.000275	0.00433	CcSEcCtD
Epinephrine—ADRB1—cardiovascular system—obesity	0.000273	0.0144	CbGeAlD
Epinephrine—Dizziness—Benzphetamine—obesity	0.00027	0.00425	CcSEcCtD
Epinephrine—Psychotic disorder—Sibutramine—obesity	0.000267	0.00421	CcSEcCtD
Epinephrine—Memory impairment—Topiramate—obesity	0.000267	0.0042	CcSEcCtD
Epinephrine—Disorientation—Bupropion—obesity	0.000267	0.0042	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Phentermine—obesity	0.000263	0.00413	CcSEcCtD
Epinephrine—Mydriasis—Topiramate—obesity	0.000262	0.00413	CcSEcCtD
Epinephrine—Tachycardia—Diethylpropion—obesity	0.000258	0.00406	CcSEcCtD
Epinephrine—ADRA1D—endocrine gland—obesity	0.000258	0.0136	CbGeAlD
Epinephrine—Hypokalaemia—Orlistat—obesity	0.000257	0.00405	CcSEcCtD
Epinephrine—SLC22A5—respiratory system—obesity	0.000257	0.0135	CbGeAlD
Epinephrine—Hyperhidrosis—Diethylpropion—obesity	0.000256	0.00403	CcSEcCtD
Epinephrine—Pallor—Topiramate—obesity	0.000253	0.00398	CcSEcCtD
Epinephrine—SLC22A1—adipose tissue—obesity	0.00025	0.0132	CbGeAlD
Epinephrine—Hypokalaemia—Sibutramine—obesity	0.000249	0.00392	CcSEcCtD
Epinephrine—Dizziness—Phendimetrazine—obesity	0.000246	0.00387	CcSEcCtD
Epinephrine—Tachycardia—Cimetidine—obesity	0.000246	0.00387	CcSEcCtD
Epinephrine—Hypoglycaemia—Bupropion—obesity	0.000244	0.00385	CcSEcCtD
Epinephrine—Cerebrovascular accident—Bupropion—obesity	0.000243	0.00383	CcSEcCtD
Epinephrine—Nausea—Benzphetamine—obesity	0.000242	0.00382	CcSEcCtD
Epinephrine—ADRB1—adipose tissue—obesity	0.000241	0.0127	CbGeAlD
Epinephrine—Insomnia—Diethylpropion—obesity	0.000239	0.00377	CcSEcCtD
Epinephrine—Sweating increased—Orlistat—obesity	0.000238	0.00375	CcSEcCtD
Epinephrine—Somnolence—Diethylpropion—obesity	0.000235	0.0037	CcSEcCtD
Epinephrine—Psychotic disorder—Bupropion—obesity	0.000233	0.00367	CcSEcCtD
Epinephrine—CYP1A2—respiratory system—obesity	0.000233	0.0123	CbGeAlD
Epinephrine—Gastrointestinal disorder—Diethylpropion—obesity	0.000228	0.0036	CcSEcCtD
Epinephrine—ADRA2A—islet of Langerhans—obesity	0.000227	0.0119	CbGeAlD
Epinephrine—Drug interaction—Topiramate—obesity	0.000226	0.00355	CcSEcCtD
Epinephrine—ADRA2C—adrenal cortex—obesity	0.000225	0.0119	CbGeAlD
Epinephrine—Somnolence—Cimetidine—obesity	0.000224	0.00352	CcSEcCtD
Epinephrine—Nausea—Phendimetrazine—obesity	0.000221	0.00348	CcSEcCtD
Epinephrine—SLC22A5—adrenal cortex—obesity	0.000216	0.0114	CbGeAlD
Epinephrine—ADRA1A—cardiovascular system—obesity	0.000216	0.0114	CbGeAlD
Epinephrine—Renal failure—Orlistat—obesity	0.000214	0.00337	CcSEcCtD
Epinephrine—Hyperglycaemia—Sibutramine—obesity	0.000213	0.00336	CcSEcCtD
Epinephrine—Dizziness—Phenylpropanolamine—obesity	0.00021	0.00331	CcSEcCtD
Epinephrine—Acute coronary syndrome—Sibutramine—obesity	0.000208	0.00327	CcSEcCtD
Epinephrine—Renal failure—Sibutramine—obesity	0.000207	0.00326	CcSEcCtD
Epinephrine—Myocardial infarction—Sibutramine—obesity	0.000207	0.00325	CcSEcCtD
Epinephrine—Sweating—Sibutramine—obesity	0.000202	0.00318	CcSEcCtD
Epinephrine—Vomiting—Phenylpropanolamine—obesity	0.000202	0.00318	CcSEcCtD
Epinephrine—Dizziness—Phentermine—obesity	0.000201	0.00317	CcSEcCtD
Epinephrine—Sweating increased—Bupropion—obesity	0.000201	0.00316	CcSEcCtD
Epinephrine—Arbutamine—ADRB3—obesity	0.0002	0.0633	CrCbGaD
Epinephrine—Haemoglobin—Orlistat—obesity	0.000197	0.00309	CcSEcCtD
Epinephrine—Haemorrhage—Orlistat—obesity	0.000196	0.00308	CcSEcCtD
Epinephrine—SLC22A1—endocrine gland—obesity	0.000194	0.0102	CbGeAlD
Epinephrine—Vomiting—Phentermine—obesity	0.000193	0.00304	CcSEcCtD
Epinephrine—Haemoglobin—Sibutramine—obesity	0.00019	0.00299	CcSEcCtD
Epinephrine—ADRA1A—adipose tissue—obesity	0.00019	0.01	CbGeAlD
Epinephrine—Haemorrhage—Sibutramine—obesity	0.000189	0.00298	CcSEcCtD
Epinephrine—Nausea—Phenylpropanolamine—obesity	0.000189	0.00297	CcSEcCtD
Epinephrine—Hypoaesthesia—Sibutramine—obesity	0.000188	0.00296	CcSEcCtD
Epinephrine—ADRB1—endocrine gland—obesity	0.000187	0.00985	CbGeAlD
Epinephrine—Hyperglycaemia—Bupropion—obesity	0.000186	0.00293	CcSEcCtD
Epinephrine—ADRA2C—pituitary gland—obesity	0.000182	0.00958	CbGeAlD
Epinephrine—ADRA2C—adipose tissue—obesity	0.000181	0.00954	CbGeAlD
Epinephrine—Acute coronary syndrome—Bupropion—obesity	0.000181	0.00285	CcSEcCtD
Epinephrine—Nausea—Phentermine—obesity	0.000181	0.00284	CcSEcCtD
Epinephrine—Myocardial infarction—Bupropion—obesity	0.00018	0.00284	CcSEcCtD
Epinephrine—Sweating—Bupropion—obesity	0.000176	0.00277	CcSEcCtD
Epinephrine—SLC22A1—liver—obesity	0.000175	0.00923	CbGeAlD
Epinephrine—Dizziness—Diethylpropion—obesity	0.000175	0.00275	CcSEcCtD
Epinephrine—SLC22A5—pituitary gland—obesity	0.000174	0.00918	CbGeAlD
Epinephrine—SLC22A5—adipose tissue—obesity	0.000174	0.00914	CbGeAlD
Epinephrine—Mental disorder—Orlistat—obesity	0.000171	0.0027	CcSEcCtD
Epinephrine—ADRA1A—adrenal gland—obesity	0.000171	0.00898	CbGeAlD
Epinephrine—Disorientation—Topiramate—obesity	0.00017	0.00267	CcSEcCtD
Epinephrine—CYP2C9—cardiovascular system—obesity	0.000169	0.00891	CbGeAlD
Epinephrine—Arrhythmia—Sibutramine—obesity	0.000169	0.00266	CcSEcCtD
Epinephrine—Vomiting—Diethylpropion—obesity	0.000168	0.00265	CcSEcCtD
Epinephrine—Dizziness—Cimetidine—obesity	0.000166	0.00262	CcSEcCtD
Epinephrine—Haemoglobin—Bupropion—obesity	0.000166	0.00261	CcSEcCtD
Epinephrine—Haemorrhage—Bupropion—obesity	0.000165	0.0026	CcSEcCtD
Epinephrine—Hallucination—Bupropion—obesity	0.000164	0.00258	CcSEcCtD
Epinephrine—Hypoaesthesia—Bupropion—obesity	0.000164	0.00258	CcSEcCtD
Epinephrine—SLC22A5—digestive system—obesity	0.000163	0.00861	CbGeAlD
Epinephrine—ADRA2C—adrenal gland—obesity	0.000163	0.00856	CbGeAlD
Epinephrine—Tension—Sibutramine—obesity	0.000162	0.00255	CcSEcCtD
Epinephrine—Nervousness—Sibutramine—obesity	0.00016	0.00252	CcSEcCtD
Epinephrine—Vomiting—Cimetidine—obesity	0.00016	0.00252	CcSEcCtD
Epinephrine—Nausea—Diethylpropion—obesity	0.000157	0.00247	CcSEcCtD
Epinephrine—SLC22A5—adrenal gland—obesity	0.000156	0.0082	CbGeAlD
Epinephrine—Hypoglycaemia—Topiramate—obesity	0.000156	0.00245	CcSEcCtD
Epinephrine—Flushing—Bupropion—obesity	0.000153	0.00241	CcSEcCtD
Epinephrine—Agitation—Sibutramine—obesity	0.000151	0.00238	CcSEcCtD
Epinephrine—Orciprenaline—ADRB2—obesity	0.000151	0.0479	CrCbGaD
Epinephrine—Palpitations—Orlistat—obesity	0.00015	0.00237	CcSEcCtD
Epinephrine—Nausea—Cimetidine—obesity	0.00015	0.00235	CcSEcCtD
Epinephrine—Psychotic disorder—Topiramate—obesity	0.000148	0.00234	CcSEcCtD
Epinephrine—CYP1A2—digestive system—obesity	0.000148	0.0078	CbGeAlD
Epinephrine—ADRA1A—endocrine gland—obesity	0.000148	0.00779	CbGeAlD
Epinephrine—Arrhythmia—Bupropion—obesity	0.000147	0.00232	CcSEcCtD
Epinephrine—Palpitations—Sibutramine—obesity	0.000146	0.00229	CcSEcCtD
Epinephrine—ADRA2A—pituitary gland—obesity	0.000145	0.00765	CbGeAlD
Epinephrine—Chest pain—Orlistat—obesity	0.000145	0.00228	CcSEcCtD
Epinephrine—Pirbuterol—ADRB1—obesity	0.000145	0.0459	CrCbGaD
Epinephrine—ADRA2A—adipose tissue—obesity	0.000145	0.00762	CbGeAlD
Epinephrine—Mental disorder—Bupropion—obesity	0.000145	0.00228	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000144	0.00227	CcSEcCtD
Epinephrine—Hypertension—Sibutramine—obesity	0.000142	0.00224	CcSEcCtD
Epinephrine—Tension—Bupropion—obesity	0.000141	0.00222	CcSEcCtD
Epinephrine—CYP2C9—digestive system—obesity	0.000141	0.0074	CbGeAlD
Epinephrine—Chest pain—Sibutramine—obesity	0.00014	0.00221	CcSEcCtD
Epinephrine—Nervousness—Bupropion—obesity	0.00014	0.0022	CcSEcCtD
Epinephrine—Hypokalaemia—Topiramate—obesity	0.000138	0.00218	CcSEcCtD
Epinephrine—Nervous system disorder—Orlistat—obesity	0.000136	0.00215	CcSEcCtD
Epinephrine—Skin disorder—Orlistat—obesity	0.000135	0.00212	CcSEcCtD
Epinephrine—Hyperhidrosis—Orlistat—obesity	0.000134	0.00211	CcSEcCtD
Epinephrine—ADRA1A—liver—obesity	0.000133	0.00702	CbGeAlD
Epinephrine—Dipivefrin—BCHE—obesity	0.000133	0.0422	CrCbGaD
Epinephrine—Agitation—Bupropion—obesity	0.000132	0.00208	CcSEcCtD
Epinephrine—Tachycardia—Sibutramine—obesity	0.000131	0.00207	CcSEcCtD
Epinephrine—Skin disorder—Sibutramine—obesity	0.000131	0.00206	CcSEcCtD
Epinephrine—Methyldopa—COMT—obesity	0.000131	0.0414	CrCbGaD
Epinephrine—Hyperhidrosis—Sibutramine—obesity	0.00013	0.00205	CcSEcCtD
Epinephrine—ADRA2A—adrenal gland—obesity	0.00013	0.00683	CbGeAlD
Epinephrine—Sweating increased—Topiramate—obesity	0.000128	0.00201	CcSEcCtD
Epinephrine—ADRA2C—liver—obesity	0.000127	0.00669	CbGeAlD
Epinephrine—Palpitations—Bupropion—obesity	0.000127	0.002	CcSEcCtD
Epinephrine—Insomnia—Orlistat—obesity	0.000126	0.00198	CcSEcCtD
Epinephrine—Paraesthesia—Orlistat—obesity	0.000125	0.00196	CcSEcCtD
Epinephrine—Hypertension—Bupropion—obesity	0.000124	0.00195	CcSEcCtD
Epinephrine—CYP1A2—endocrine gland—obesity	0.000122	0.00644	CbGeAlD
Epinephrine—Chest pain—Bupropion—obesity	0.000122	0.00193	CcSEcCtD
Epinephrine—SLC22A5—liver—obesity	0.000122	0.00641	CbGeAlD
Epinephrine—Pirbuterol—ADRB2—obesity	0.000122	0.0386	CrCbGaD
Epinephrine—Insomnia—Sibutramine—obesity	0.000122	0.00191	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000121	0.00191	CcSEcCtD
Epinephrine—Paraesthesia—Sibutramine—obesity	0.000121	0.0019	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Orlistat—obesity	0.00012	0.00189	CcSEcCtD
Epinephrine—Somnolence—Sibutramine—obesity	0.00012	0.00188	CcSEcCtD
Epinephrine—Hyperglycaemia—Topiramate—obesity	0.000118	0.00187	CcSEcCtD
Epinephrine—CYP2C9—endocrine gland—obesity	0.000116	0.00611	CbGeAlD
Epinephrine—Gastrointestinal disorder—Sibutramine—obesity	0.000116	0.00183	CcSEcCtD
Epinephrine—Terbutaline—BCHE—obesity	0.000115	0.0366	CrCbGaD
Epinephrine—Renal failure—Topiramate—obesity	0.000115	0.00181	CcSEcCtD
Epinephrine—Nervous system disorder—Bupropion—obesity	0.000115	0.00181	CcSEcCtD
Epinephrine—Droxidopa—ADRB3—obesity	0.000115	0.0364	CrCbGaD
Epinephrine—Tachycardia—Bupropion—obesity	0.000114	0.0018	CcSEcCtD
Epinephrine—Dipivefrin—ADRB2—obesity	0.000114	0.0363	CrCbGaD
Epinephrine—Skin disorder—Bupropion—obesity	0.000114	0.00179	CcSEcCtD
Epinephrine—Isoetarine—ADRB1—obesity	0.000114	0.036	CrCbGaD
Epinephrine—Hyperhidrosis—Bupropion—obesity	0.000113	0.00178	CcSEcCtD
Epinephrine—ADRA2A—endocrine gland—obesity	0.000113	0.00592	CbGeAlD
Epinephrine—CYP1A2—liver—obesity	0.00011	0.00581	CbGeAlD
Epinephrine—CYP3A4—digestive system—obesity	0.000107	0.00564	CbGeAlD
Epinephrine—Insomnia—Bupropion—obesity	0.000106	0.00167	CcSEcCtD
Epinephrine—Haemoglobin—Topiramate—obesity	0.000106	0.00166	CcSEcCtD
Epinephrine—Paraesthesia—Bupropion—obesity	0.000105	0.00166	CcSEcCtD
Epinephrine—Haemorrhage—Topiramate—obesity	0.000105	0.00166	CcSEcCtD
Epinephrine—CYP2C9—liver—obesity	0.000105	0.00551	CbGeAlD
Epinephrine—Hallucination—Topiramate—obesity	0.000105	0.00165	CcSEcCtD
Epinephrine—Hypoaesthesia—Topiramate—obesity	0.000105	0.00165	CcSEcCtD
Epinephrine—Isoprenaline—ADRB3—obesity	0.000104	0.0331	CrCbGaD
Epinephrine—Somnolence—Bupropion—obesity	0.000104	0.00164	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Bupropion—obesity	0.000101	0.00159	CcSEcCtD
Epinephrine—Terbutaline—ADRB2—obesity	9.92e-05	0.0315	CrCbGaD
Epinephrine—Flushing—Topiramate—obesity	9.76e-05	0.00154	CcSEcCtD
Epinephrine—Norepinephrine—ADRB3—obesity	9.65e-05	0.0306	CrCbGaD
Epinephrine—Isoetarine—ADRB2—obesity	9.55e-05	0.0303	CrCbGaD
Epinephrine—Mental disorder—Topiramate—obesity	9.21e-05	0.00145	CcSEcCtD
Epinephrine—Dizziness—Orlistat—obesity	9.19e-05	0.00145	CcSEcCtD
Epinephrine—Erythema—Topiramate—obesity	9.15e-05	0.00144	CcSEcCtD
Epinephrine—Arbutamine—ADRB1—obesity	9.03e-05	0.0286	CrCbGaD
Epinephrine—Tension—Topiramate—obesity	8.98e-05	0.00141	CcSEcCtD
Epinephrine—Dizziness—Sibutramine—obesity	8.89e-05	0.0014	CcSEcCtD
Epinephrine—Nervousness—Topiramate—obesity	8.89e-05	0.0014	CcSEcCtD
Epinephrine—CYP3A4—endocrine gland—obesity	8.86e-05	0.00466	CbGeAlD
Epinephrine—Vomiting—Orlistat—obesity	8.83e-05	0.00139	CcSEcCtD
Epinephrine—Salbutamol—ADRB1—obesity	8.77e-05	0.0278	CrCbGaD
Epinephrine—Vomiting—Sibutramine—obesity	8.55e-05	0.00135	CcSEcCtD
Epinephrine—Agitation—Topiramate—obesity	8.41e-05	0.00132	CcSEcCtD
Epinephrine—Nausea—Orlistat—obesity	8.25e-05	0.0013	CcSEcCtD
Epinephrine—Palpitations—Topiramate—obesity	8.09e-05	0.00127	CcSEcCtD
Epinephrine—Nausea—Sibutramine—obesity	7.99e-05	0.00126	CcSEcCtD
Epinephrine—CYP3A4—liver—obesity	7.98e-05	0.0042	CbGeAlD
Epinephrine—Hypertension—Topiramate—obesity	7.9e-05	0.00124	CcSEcCtD
Epinephrine—Chest pain—Topiramate—obesity	7.79e-05	0.00123	CcSEcCtD
Epinephrine—Dizziness—Bupropion—obesity	7.75e-05	0.00122	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	7.74e-05	0.00122	CcSEcCtD
Epinephrine—Arbutamine—ADRB2—obesity	7.59e-05	0.0241	CrCbGaD
Epinephrine—Vomiting—Bupropion—obesity	7.45e-05	0.00117	CcSEcCtD
Epinephrine—Salbutamol—ADRB2—obesity	7.37e-05	0.0234	CrCbGaD
Epinephrine—Nervous system disorder—Topiramate—obesity	7.32e-05	0.00115	CcSEcCtD
Epinephrine—Tachycardia—Topiramate—obesity	7.29e-05	0.00115	CcSEcCtD
Epinephrine—Skin disorder—Topiramate—obesity	7.26e-05	0.00114	CcSEcCtD
Epinephrine—Hyperhidrosis—Topiramate—obesity	7.22e-05	0.00114	CcSEcCtD
Epinephrine—Nausea—Bupropion—obesity	6.96e-05	0.0011	CcSEcCtD
Epinephrine—Insomnia—Topiramate—obesity	6.76e-05	0.00106	CcSEcCtD
Epinephrine—Paraesthesia—Topiramate—obesity	6.71e-05	0.00106	CcSEcCtD
Epinephrine—Somnolence—Topiramate—obesity	6.64e-05	0.00105	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Topiramate—obesity	6.45e-05	0.00102	CcSEcCtD
Epinephrine—Dopamine—COMT—obesity	6.37e-05	0.0202	CrCbGaD
Epinephrine—Norepinephrine—SLC22A1—obesity	5.75e-05	0.0182	CrCbGaD
Epinephrine—L-DOPA—DRD4—obesity	5.56e-05	0.0176	CrCbGaD
Epinephrine—Dopamine—SLC22A1—obesity	5.35e-05	0.017	CrCbGaD
Epinephrine—Droxidopa—ADRB1—obesity	5.19e-05	0.0164	CrCbGaD
Epinephrine—Dopamine—DRD4—obesity	5.17e-05	0.0164	CrCbGaD
Epinephrine—Dizziness—Topiramate—obesity	4.94e-05	0.000778	CcSEcCtD
Epinephrine—Vomiting—Topiramate—obesity	4.75e-05	0.000748	CcSEcCtD
Epinephrine—Isoprenaline—ADRB1—obesity	4.71e-05	0.0149	CrCbGaD
Epinephrine—L-DOPA—DRD1—obesity	4.7e-05	0.0149	CrCbGaD
Epinephrine—Nausea—Topiramate—obesity	4.44e-05	0.000698	CcSEcCtD
Epinephrine—Dopamine—DRD1—obesity	4.37e-05	0.0139	CrCbGaD
Epinephrine—Norepinephrine—ADRB1—obesity	4.37e-05	0.0138	CrCbGaD
Epinephrine—Droxidopa—ADRB2—obesity	4.36e-05	0.0138	CrCbGaD
Epinephrine—Dopamine—ADRB1—obesity	4.06e-05	0.0129	CrCbGaD
Epinephrine—Isoprenaline—ADRB2—obesity	3.96e-05	0.0126	CrCbGaD
Epinephrine—Norepinephrine—ADRB2—obesity	3.67e-05	0.0116	CrCbGaD
Epinephrine—Norepinephrine—DRD2—obesity	3.32e-05	0.0105	CrCbGaD
Epinephrine—L-DOPA—DRD2—obesity	3.32e-05	0.0105	CrCbGaD
Epinephrine—Dopamine—SLC6A4—obesity	3.1e-05	0.00983	CrCbGaD
Epinephrine—Dopamine—DRD2—obesity	3.08e-05	0.00977	CrCbGaD
Epinephrine—ADRA2C—Signaling Pathways—TYK2—obesity	8.36e-07	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—obesity	8.34e-07	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—obesity	8.34e-07	1.01e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKR1C3—obesity	8.32e-07	1.01e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RHOA—obesity	8.29e-07	1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BAD—obesity	8.29e-07	1e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PIK3CA—obesity	8.26e-07	1e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TYK2—obesity	8.23e-07	9.96e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—POMC—obesity	8.23e-07	9.96e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—obesity	8.21e-07	9.94e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3R1—obesity	8.21e-07	9.94e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NOS3—obesity	8.21e-07	9.94e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—LPL—obesity	8.2e-07	9.93e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SCARB1—obesity	8.19e-07	9.91e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MTOR—obesity	8.19e-07	9.91e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CB—obesity	8.19e-07	9.91e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—INS—obesity	8.18e-07	9.91e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RHOA—obesity	8.16e-07	9.88e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CB—obesity	8.11e-07	9.82e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MTOR—obesity	8.11e-07	9.82e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3R1—obesity	8.08e-07	9.78e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NOS3—obesity	8.08e-07	9.78e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCL2—obesity	8.05e-07	9.75e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CG—obesity	8.03e-07	9.72e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MTOR—obesity	8.01e-07	9.69e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CB—obesity	8.01e-07	9.69e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—obesity	8e-07	9.69e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—NOS3—obesity	7.97e-07	9.65e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3R1—obesity	7.97e-07	9.65e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SREBF1—obesity	7.95e-07	9.62e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IRS1—obesity	7.94e-07	9.61e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—obesity	7.92e-07	9.58e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT2—obesity	7.91e-07	9.57e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PIK3CA—obesity	7.82e-07	9.46e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—obesity	7.81e-07	9.45e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—COMT—obesity	7.81e-07	9.45e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CD36—obesity	7.79e-07	9.43e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GOT2—obesity	7.74e-07	9.36e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARGC1A—obesity	7.7e-07	9.32e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNB3—obesity	7.7e-07	9.32e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PIK3CA—obesity	7.7e-07	9.32e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—HMOX1—obesity	7.66e-07	9.28e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—POMC—obesity	7.65e-07	9.25e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—INS—obesity	7.6e-07	9.2e-06	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—obesity	7.6e-07	9.2e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CD—obesity	7.6e-07	9.2e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MAPK8—obesity	7.6e-07	9.19e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MTOR—obesity	7.58e-07	9.17e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CB—obesity	7.58e-07	9.17e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—obesity	7.57e-07	9.17e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—FASN—obesity	7.57e-07	9.16e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BCHE—obesity	7.54e-07	9.12e-06	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—obesity	7.53e-07	9.12e-06	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—PIK3CA—obesity	7.53e-07	9.11e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SERPINE1—obesity	7.52e-07	9.1e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNAS—obesity	7.5e-07	9.07e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—obesity	7.48e-07	9.06e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCL2—obesity	7.48e-07	9.06e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MTOR—obesity	7.46e-07	9.03e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CB—obesity	7.46e-07	9.03e-06	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—obesity	7.45e-07	9.01e-06	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—obesity	7.43e-07	9e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—obesity	7.41e-07	8.97e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—obesity	7.39e-07	8.94e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CB—obesity	7.36e-07	8.91e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—obesity	7.35e-07	8.9e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT2—obesity	7.35e-07	8.9e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOB—obesity	7.34e-07	8.89e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—obesity	7.32e-07	8.86e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TYK2—obesity	7.31e-07	8.85e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—obesity	7.29e-07	8.83e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP2E1—obesity	7.27e-07	8.8e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RHOA—obesity	7.25e-07	8.78e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARA—obesity	7.25e-07	8.77e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NQO1—obesity	7.19e-07	8.7e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NOS3—obesity	7.18e-07	8.69e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3R1—obesity	7.18e-07	8.69e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—obesity	7.12e-07	8.61e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CD—obesity	7.06e-07	8.55e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—obesity	7.05e-07	8.53e-06	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—obesity	7.03e-07	8.51e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AGT—obesity	7.02e-07	8.49e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—LPL—obesity	7.01e-07	8.48e-06	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—PIK3CA—obesity	6.99e-07	8.47e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SERPINE1—obesity	6.98e-07	8.45e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—obesity	6.96e-07	8.43e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—obesity	6.94e-07	8.41e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—obesity	6.92e-07	8.38e-06	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—obesity	6.92e-07	8.38e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MAPK8—obesity	6.92e-07	8.38e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—obesity	6.9e-07	8.35e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GCG—obesity	6.89e-07	8.35e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC2A4—obesity	6.89e-07	8.35e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOE—obesity	6.88e-07	8.32e-06	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—obesity	6.87e-07	8.31e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MAPK8—obesity	6.86e-07	8.3e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—obesity	6.84e-07	8.28e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—obesity	6.84e-07	8.28e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PIK3CA—obesity	6.84e-07	8.27e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—obesity	6.81e-07	8.25e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CAV1—obesity	6.81e-07	8.25e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYCS—obesity	6.8e-07	8.24e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—APOA1—obesity	6.8e-07	8.23e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TYK2—obesity	6.79e-07	8.22e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MAPK8—obesity	6.77e-07	8.19e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—obesity	6.75e-07	8.17e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RHOA—obesity	6.74e-07	8.15e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GGT1—obesity	6.68e-07	8.08e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GOT1—obesity	6.68e-07	8.08e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NOS3—obesity	6.67e-07	8.07e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3R1—obesity	6.67e-07	8.07e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CD36—obesity	6.66e-07	8.06e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MTOR—obesity	6.62e-07	8.02e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CB—obesity	6.62e-07	8.02e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—obesity	6.59e-07	7.97e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NCOA1—obesity	6.58e-07	7.96e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.51e-07	7.88e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—obesity	6.48e-07	7.85e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—STK11—obesity	6.48e-07	7.85e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP19A1—obesity	6.48e-07	7.85e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—obesity	6.45e-07	7.81e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—obesity	6.44e-07	7.79e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MAPK8—obesity	6.41e-07	7.75e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—obesity	6.39e-07	7.73e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PIK3CA—obesity	6.35e-07	7.69e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—obesity	6.33e-07	7.66e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—obesity	6.31e-07	7.64e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MAPK8—obesity	6.3e-07	7.63e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—obesity	6.29e-07	7.61e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—obesity	6.27e-07	7.59e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CG—obesity	6.21e-07	7.51e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARA—obesity	6.19e-07	7.49e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—obesity	6.19e-07	7.49e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CB—obesity	6.15e-07	7.45e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MTOR—obesity	6.15e-07	7.45e-06	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—obesity	6.15e-07	7.44e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—obesity	6.05e-07	7.33e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—COMT—obesity	6.03e-07	7.29e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AGT—obesity	6e-07	7.26e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PPARG—obesity	5.99e-07	7.25e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNB3—obesity	5.94e-07	7.19e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARGC1A—obesity	5.94e-07	7.19e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HMOX1—obesity	5.92e-07	7.16e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—POMC—obesity	5.91e-07	7.15e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—obesity	5.88e-07	7.12e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOE—obesity	5.88e-07	7.11e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—INS—obesity	5.87e-07	7.11e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—obesity	5.86e-07	7.1e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—obesity	5.86e-07	7.09e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—obesity	5.83e-07	7.05e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CAV1—obesity	5.82e-07	7.05e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—obesity	5.81e-07	7.03e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—APOA1—obesity	5.81e-07	7.03e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNAS—obesity	5.79e-07	7e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—obesity	5.76e-07	6.98e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—obesity	5.76e-07	6.97e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—obesity	5.75e-07	6.96e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—obesity	5.74e-07	6.94e-06	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—obesity	5.71e-07	6.92e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PIK3CA—obesity	5.68e-07	6.87e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOB—obesity	5.67e-07	6.86e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—obesity	5.62e-07	6.81e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MAPK8—obesity	5.6e-07	6.78e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—obesity	5.58e-07	6.76e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.56e-07	6.73e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PIK3CA—obesity	5.52e-07	6.69e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PIK3CA—obesity	5.48e-07	6.63e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CD—obesity	5.46e-07	6.6e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—obesity	5.44e-07	6.59e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—obesity	5.43e-07	6.57e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—LPL—obesity	5.41e-07	6.55e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—obesity	5.39e-07	6.52e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—obesity	5.36e-07	6.48e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—obesity	5.35e-07	6.48e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—obesity	5.34e-07	6.47e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CG—obesity	5.3e-07	6.42e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PIK3CA—obesity	5.29e-07	6.41e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—obesity	5.28e-07	6.39e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MAPK8—obesity	5.2e-07	6.3e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—obesity	5.19e-07	6.28e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NOS3—obesity	5.15e-07	6.24e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3R1—obesity	5.15e-07	6.24e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CD36—obesity	5.14e-07	6.22e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—obesity	5.12e-07	6.2e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PPARG—obesity	5.12e-07	6.19e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—POMC—obesity	5.05e-07	6.11e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—INS—obesity	5.02e-07	6.08e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PIK3CA—obesity	4.99e-07	6.04e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PIK3CA—obesity	4.95e-07	5.99e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PIK3CA—obesity	4.88e-07	5.91e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—obesity	4.87e-07	5.9e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—obesity	4.85e-07	5.87e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARA—obesity	4.78e-07	5.78e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—obesity	4.76e-07	5.76e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—obesity	4.76e-07	5.76e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CB—obesity	4.76e-07	5.76e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—obesity	4.75e-07	5.74e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—obesity	4.71e-07	5.7e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CD—obesity	4.66e-07	5.64e-06	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—obesity	4.64e-07	5.62e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AGT—obesity	4.63e-07	5.6e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PIK3CA—obesity	4.62e-07	5.59e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—obesity	4.6e-07	5.57e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PIK3CA—obesity	4.55e-07	5.5e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOE—obesity	4.53e-07	5.49e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—obesity	4.51e-07	5.46e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CAV1—obesity	4.49e-07	5.44e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PIK3CA—obesity	4.49e-07	5.43e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—APOA1—obesity	4.48e-07	5.43e-06	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—obesity	4.47e-07	5.42e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—obesity	4.42e-07	5.35e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—obesity	4.42e-07	5.35e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—obesity	4.41e-07	5.34e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NOS3—obesity	4.4e-07	5.33e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3R1—obesity	4.4e-07	5.33e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—obesity	4.38e-07	5.3e-06	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—obesity	4.32e-07	5.23e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—obesity	4.32e-07	5.23e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CG—obesity	4.09e-07	4.95e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—obesity	4.09e-07	4.95e-06	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—obesity	4.08e-07	4.93e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CB—obesity	4.06e-07	4.92e-06	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—obesity	4.04e-07	4.89e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PIK3CA—obesity	4.04e-07	4.89e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—obesity	4.03e-07	4.87e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—obesity	4.03e-07	4.87e-06	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—obesity	3.99e-07	4.83e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PPARG—obesity	3.95e-07	4.78e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—POMC—obesity	3.9e-07	4.72e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—INS—obesity	3.87e-07	4.69e-06	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—obesity	3.77e-07	4.57e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PIK3CA—obesity	3.75e-07	4.54e-06	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—obesity	3.71e-07	4.5e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—obesity	3.67e-07	4.44e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CD—obesity	3.6e-07	4.35e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—obesity	3.58e-07	4.33e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—obesity	3.55e-07	4.3e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3R1—obesity	3.4e-07	4.11e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NOS3—obesity	3.4e-07	4.11e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—obesity	3.32e-07	4.02e-06	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—obesity	3.3e-07	3.99e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CB—obesity	3.14e-07	3.8e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—obesity	3.11e-07	3.76e-06	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—obesity	3.07e-07	3.71e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PIK3CA—obesity	2.9e-07	3.51e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PIK3CA—obesity	2.48e-07	3e-06	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—obesity	2.37e-07	2.87e-06	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—obesity	2.02e-07	2.45e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PIK3CA—obesity	1.91e-07	2.31e-06	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—obesity	1.56e-07	1.89e-06	CbGpPWpGaD
